A matched analysis of the use of high flow nasal cannula for pediatric severe acute asthma.
Colin M RogersonSamer AbuSultanehL Nelson Sanchez-PintoBenjamin GastonSarah WieheTitus SchleyerWanzhu TuEneida MendoncaPublished in: Pediatric pulmonology (2024)
Encounters using HFNC for severe acute pediatric asthma had decreased clinical improvement in 24 h of hospitalization compared to matched controls and increased LOS. Specific subgroups of younger patients and those with the highest severity scores showed no differences in clinical symptom improvement suggesting differential effects in specific patient populations.
Keyphrases
- chronic obstructive pulmonary disease
- end stage renal disease
- lung function
- newly diagnosed
- ejection fraction
- chronic kidney disease
- allergic rhinitis
- peritoneal dialysis
- prognostic factors
- extracorporeal membrane oxygenation
- case report
- patient reported
- young adults
- intensive care unit
- cystic fibrosis
- obstructive sleep apnea
- respiratory failure
- childhood cancer